Abstract: Nitric oxide (NO) is an essential signaling molecule within biological systems and is believed to be involved in numerous diseases. As a result of NO's high reaction rate, the detection of the concentration of NO, let alone the presence or absence of the molecule, is extremely difficult. Researchers have developed multiple assays and probes in an attempt to quantify NO within biological solutions, each of which has advantages and disadvantages. This review highlights many of the current NO sensors, from those that are commercially available to the newest sensors being optimized in research labs, to assist in the understanding and utilization of NO sensors in biological fields.
Introduction
Nitric oxide (NO) is a molecule that has recently attracted heightened interest due to its vast role in human health and biology. Nearly 35 years ago NO was identified as an endothelial relaxing factor, a discovery which garnered Robert F. Furchgott, Ferid Murad, and Louis J. Ignarro a Nobel prize for medicine or physiology in 1998 [1] . However, in the past 20 years NO has also been shown to play a significant role in a multitude of physiological systems including the central nervous system (CNS), the cardiovascular system, the gastrointestinal tract, the immune system, and the renal system [2] [3] [4] [5] [6] .
Within the CNS, NO acts as a neurotransmitter, and it has been shown to regulate feelings of pain, appetite, the sleep-wake cycle, thermoregulation, synaptic plasticity, and neural secretion [2, [7] [8] [9] [10] [11] [12] [13] . NO may also act as a neuroprotective or degradative agent, depending upon its concentration within the surrounding tissue [2, [14] [15] [16] . Aside from its aforementioned role in vasodilation, NO also plays a significant role in the modulation of platelet aggregation, smooth muscle cell proliferation, and LDL (low density lipoprotein) cholesterol oxidation within the cardiovascular system [1, [17] [18] [19] .
Within the gastrointestinal tract, NO protects the stomach epithelium by stimulating mucosal and bicarbonate secretions [4, 20, 21] . NO may also confer protection to the mucosal layer by inhibiting gastric acid secretion and leukocyte adhesion to the epithelium [4, 5, 22, 23] .
The role of NO within the immune system is immense, and while much is known about some specific roles of NO, its behavior outside of norms is still largely uncharted. A well-known role of NO within the immune system is its antitumor and microbial effects. Macrophage-derived NO can cause tumor cells senescence or death [5, 24] . Cytotoxic lymphocytes can also induce NO expression within tumor cells via interferon-γ and tumor necrosis factor (TNF), again resulting in senescence or death [5, 25] . Paradoxically, it is not uncommon for tumor cells to constitutively express NO, aiding in tumor growth by increasing neovascularization and upregulating the production of DNA dependent protein kinases (DNA-PKcs), which are required for DNA repair [5, 26, 27] . In addition to antitumor effects, NO has been shown to display significant antimicrobial properties and its expression by immune and epithelial cells has been shown to decrease replication and kill infectious agents [5, 28] .
In the renal system, NO is principally responsible for regulating blood pressure and flow to the kidneys [29] . NO has also been implicated in natriuresis and diuresis due to its ability to inhibit sodium transport within the nephron [6] .
As a result of NO's widespread impact on cell and tissue health, there are also numerous inflammatory diseases linked to the altered expression of NO [30] [31] [32] [33] [34] . There are both diseasepromoting and disease-inhibiting reactions in the tumor microenvironment that are associated with changes in NO concentration, which has resulted in confusion about the role of NO during disease progression [35] [36] [37] . An example of this can be seen with melanoma, a type of skin cancer, in which different researchers have shown that nitric oxide synthase (NOS) and NO are both directly and inversely correlated to apoptosis, metastasis, and disease progression [38] [39] [40] [41] .
Unsurprisingly, NO's diverse effect on numerous bodily functions has led some working in the field of human health to utilize NO in the development of new medical techniques and practices. Some more notable accomplishments utilizing NO include a reversal of hypoxic pulmonary vasoconstriction using inhaled NO, the development of an antimicrobial sol-gel for coating biomaterials used in implants, and an electrochemical oxygen probe which uses NO as an anticlotting agent [42] [43] [44] .
NO's reactivity, one of the traits that makes it such an effective signaling molecule, also makes it extremely difficult to quantify [45, 46] . The half-life of NO is largely dependent on the microenvironment into which it is released. Environments low in available bioreactive molecules will increase the half-life of NO substantially. As a result, great discrepancies exist in the accepted biological half-life of NO [47] [48] [49] . However, the generally accepted half-life for NO in blood is 0.05-1 millisecond [34, [50] [51] [52] [53] [54] , breaking down into multiple stable and non-stable molecules ( Figure  1 ) [50, [55] [56] [57] . When NO's reactivity rate is combined with its synthesis through NOS, a complicated biological system is created which cannot easily be understood. [50, [55] [56] [57] .
Before the importance of NO in biological systems can be fully understood, a sensor to detect and quantify NO needs to be developed. There are multiple sensors currently on the market or being developed in research labs, all of which have their own advantages and disadvantages. This review will cover some of the main NO sensors currently in use and in development in an attempt to elucidate the areas of sensor development success and the areas in which further research is still needed.
Upstream and Downstream Measurements
Because of NO's high reactivity rate, examining upstream or downstream indicators of NO is a popular method to estimate NO concentration within samples. The Griess assay (Promega, Madison, WI, USA) determines nitrite concentration, since it is a stable byproduct of NO, and can be utilized to calculate the concentration of NO that was present in a sample before degradation occurred. The Griess test was originally published by Peter Griess in 1879 and many alterations have been made to create the current commercially available assay, although it still relies upon the diazotization reaction that Griess originally described [58] . The Griess test is relatively simple, requiring the addition of Figure 1 . Nitric oxide (NO) has a very high reaction rate. Some of the pathways in the development and degradation of NO are shown [50, [55] [56] [57] .
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Electrochemical Detection
Electrochemical sensors are an excellent alternative for researchers that desire a fast and relatively simple method of determining NO concentration. In 1992, Malinski and Taha demonstrated the ability of their electrochemical probe, created by covering carbon fibers with polymeric porphyrin followed by a Nafion coating, to detect NO released from a single cell [71] . The Nafion coating was essential in the probe development since it is negatively charged and allows NO to pass through the coating while blocking the passage of nitrite and nitrate, two main downstream components of NO, to the sensor [71] . Shortly thereafter, Malinski's lab showed the ability of an electrochemical probe to detect NO within the vasculature of a living human and demonstrated dose dependent changes with their system [72] .
Since the original development of the electrochemical NO sensor, commercialization has led to relatively inexpensive, user-friendly instruments consisting of various materials and allowing for real-time in vitro and in vivo measurements of NO within a solution. One of the commercially available systems is amiNO (produced by Innovative Instruments, Inc., Tampa, FL, USA), which allows consumers to choose the size, flexibility, durability, sensitivity, and response time for their system, has a detection limit of 1 nM of NO, and can differentiate between 10 nM and 11 nM solutions [73] . Two substantial drawbacks of the electrochemical sensor are that it has not been miniaturized to the point of providing information about NO concentrations throughout a cell and it is not a sensor that can monitor NO over long time intervals while a subject is carrying out natural activities, both of which would be extremely valuable in understanding NO's physiological importance.
Chemiluminescent Probes
Chemiluminescent probes can be used to detect NO in both liquid and gaseous samples [74] [75] [76] [77] . The general scheme for the detection of NO in fluid samples via chemiluminescence is through the activation of guanylyl cyclase by NO exposure, causing guanosine triphosphate (GTP) to be converted to guanosine 3 ,5 -cyclic monophosphate (cGMP) which results in the release of pyrophosphate, which can then interact with adenosine triphosphate sulfurylase (ATP-sulfurylase) to form ATP [76, 77] . The ATP that is formed through this series of reactions is then able to interact with a luciferin-luciferase system to emit light at 560 nm [76, 77] . An advantage of the chemiluminescent system is that it is able to detect NO at nM concentrations, since the initial guanylyl cyclase interaction with NO leads to a 200-fold linear increase [76, 77] . Chemiluminescent probes have some disadvantages, including the inability to detect NO in vivo.
Fluorescence Probes
Fluorescence detection methods are an attractive alternative to the previously mentioned sensors because of their ability to detect both extracellular and intracellular NO as well as their ability to provide both spatial and temporal information [78] . Various types of fluorescent NO sensors have been developed, including o-diamino aromatic compounds, luminescent lanthanide complexes, transition-metal complexes, quantum dots, and carbon nanotube sensors. Each type of fluorescent sensor has different positive and negative traits; in the following, some of the major fluorescent sensors are listed with a discussion of their benefits and drawbacks.
A common approach for the generation of NO sensors is through the use of o-diamino aromatic molecules (as depicted in Figure 4 ) such as 4,5-diaminofluorescein, commonly known as DAF-2 [79] [80] [81] [82] .
Unfortunately, many of the o-diamino sensors have drawbacks, including a false positive signal when exposed to dehydroascorbic acid (DHA) and ascorbic acid (AA), which often co-localize with NO synthase, and a sensitivity to pH [83] [84] [85] . The Shear research group developed a new NO sensor in 2010, named NO 550 , that has a high specificity, does not react to co-localized proteins, and is not sensitive to pH differences, which is advantageous since various intracellular compartments have different pH values [86] [87] [88] . NO 550 shows a red-shifted 1500-fold increase in fluorescence and does not react to other reactive oxygen and nitrogen species [88] . One drawback of NO 550 is that it has limited aqueous solubility, making it less than ideal for biological studies [88] .
An alternate method for NO fluorescence detection is through the use of transition metal-based complexes, which create a turn-on fluorescent signal. For transition metal-based complexes a fluorophore is bound to a transition metal and exhibits a very weak signal, but a reaction with NO causes the displacement of the fluorophore and fluorescence recovery [89, 90] . Unfortunately, metal-based complexes are water-insoluble creating a good NO sensor for organic solvents but not being optimal for many biological scenarios [91] .
Because aqueous solubility is believed to be an important characteristic for biological sensors, Nagano's group developed a luminescent lanthanide complex that showed a 50-fold increase in luminescence (excitation 500 nm and emission 980 nm) after exposure to 50 uM aqueous NO [92] . A benefit of Nagano's sensor over previously developed Yb 3+ complexes lies in the fact that their probe is functional in aqueous systems, has an excitation wavelength that can be produced via two-photon technology, and has an emission wavelength in the near-infrared region, where water and blood absorb minimal light [92] .
In 2017, a new fluorescent NO sensor called NCNO, which is based on N-nitrosation reactivity was developed to avoid non-specific reactions from DHA, AA, and reactive oxygen species [93] . NCNO covalently binds a two-photon fluorophore to a mono alkyl-substituted p-phenylenediamine, as shown in Figure 4 [93] . Because the two-photon fluorophore has an emission wavelength greater than 600 nm, the NCNO probe can be detected deep within tissue and has been shown to detect NO generation in an ischemia reperfusion injury mouse model [93] . One of the shortcomings of the NCNO detection system is that N-nitrosation is detected, not total NO concentration, so assumptions and models need to be used to determine the actual NO concentration in the solution/tissue.
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Genetic Biosensors
An interesting new way to detect NO within a single cell is through the addition of genetic materials that will code for a visual signal response in the presence of NO [110] . Ronald Malli and colleagues developed a system in which the NO responsive transcription factor of Escherichia coli (E. coli) is conjugated to fluorescent protein variants that are then taken up by cells [110] [111] [112] . When these fluorescent probes were tested with HeLa cells they were shown to be taken up and expressed at similar rates compared to other genetically encoded probes [110] . The NO probes were shown to respond to NO immediately with a reversible signal, allowing for long term NO dynamics investigations within cells in vitro [110] . Ongoing research efforts are looking at the possibility of utilizing this system to develop an in vivo model [110] . One major obstacle that still prevents the utilization of the probes in vivo is that the fluorescence emission range that is currently being utilized is difficult to visualize at any depth within tissue. 
Conclusions
Nitric oxide is an essential reactive species within biological systems. As researchers are able to understand the many complex reactions associated with NO, a deeper understanding of healthy and diseased cells, tissues, and organisms will be uncovered. Before researchers can understand NO's role in biological functions there must be a way to accurately measure NO both in vitro and in vivo. Current sensor methods, many of which are outlined in Table 1 , are greatly improved over those from just 10 or 20 years ago, and hopefully further progress can be made within the coming years.
